HZ case characteristics
| Age at HCT, y . | VZV IgG . | Prior HZ . | Stem cell source . | HLA matching . | Time between V1 and V2, d . | Time from HCT to HZ, d . | Time from V2 to HZ, d . | Time from antiviral discontinuation to HZ, d . | Immunosuppression at HZ . | Clinical presentation . |
|---|---|---|---|---|---|---|---|---|---|---|
| 22* | + | No | Bone marrow | Matched unrelated | 49 | 383 | 10 | 10 | None | Dermatomal |
| 47 | + | Yes | Cord blood | Mismatched unrelated | 63 | 668 | 102 | 41 | None | Disseminated cutaneous, pneumonia, hepatitis, death |
| 68 | + | No | Peripheral blood | Matched related | 91 | 743 | 115 | 206 | None | Dermatomal |
| 25 | + | No | Peripheral blood | Matched related | 140 | 911 | 51 | 9 | None | Dermatomal |
| Age at HCT, y . | VZV IgG . | Prior HZ . | Stem cell source . | HLA matching . | Time between V1 and V2, d . | Time from HCT to HZ, d . | Time from V2 to HZ, d . | Time from antiviral discontinuation to HZ, d . | Immunosuppression at HZ . | Clinical presentation . |
|---|---|---|---|---|---|---|---|---|---|---|
| 22* | + | No | Bone marrow | Matched unrelated | 49 | 383 | 10 | 10 | None | Dermatomal |
| 47 | + | Yes | Cord blood | Mismatched unrelated | 63 | 668 | 102 | 41 | None | Disseminated cutaneous, pneumonia, hepatitis, death |
| 68 | + | No | Peripheral blood | Matched related | 91 | 743 | 115 | 206 | None | Dermatomal |
| 25 | + | No | Peripheral blood | Matched related | 140 | 911 | 51 | 9 | None | Dermatomal |
IgG, immunoglobulin G; +, present.
Excluded from modified TVC as the result of an HZ episode <30 days after V2.